Karen Yates

Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants

Bryan D. Smith, Michael D. Kaufman, Wei-Ping Lu et al. · Cancer Cell · 2019 · 270 citations

Pdgfra Variants, Oncogenic Agent, Medicine +9

Australian nursing students’ knowledge and attitudes towards pressure injury prevention: A cross-sectional study

Kim Usher, Cindy Woods, Janie Brown et al. · International Journal of Nursing Studies · 2018 · 91 citations

Nursing, Patient Safety, Nursing Research +8

Glycerol hyperhydration improves cycle time trial performance in hot humid conditions

Sarah Hitchins, David T. Martin, Louise M. Burke et al. · European Journal of Applied Physiology and Occupational Physiology · 1999 · 77 citations

Glycerol Hyperhydration, Physiology, Exercise Physiology +2

Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2

Bryan D. Smith, Michael D. Kaufman, Cynthia B. Leary et al. · Molecular Cancer Therapeutics · 2015 · 75 citations

Switch Control Pocket, Glioma, Tumor Biology +16

Using a community of inquiry framework to teach a nursing and midwifery research subject: An evaluative study

Jane Mills, Karen Yates, Helena Harrison et al. · Nurse Education Today · 2016 · 55 citations

Nursing, Inquiry-based Learning, Community Development +11